Aprogen Medicines Inc. (KRX:007460)

Aprogen Medicines Statistics

Total Valuation

KRX:007460 has a market cap or net worth of KRW 93.80 billion. The enterprise value is 531.20 billion.

Market Cap	93.80B
Enterprise Value	531.20B

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

KRX:007460 has 308.55 million shares outstanding. The number of shares has increased by 15.24% in one year.

Current Share Class	308.55M
Shares Outstanding	308.55M
Shares Change (YoY)	+15.24%
Shares Change (QoQ)	+2.23%
Owned by Insiders (%)	6.93%
Owned by Institutions (%)	1.94%
Float	188.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.80
PB Ratio	0.20
P/TBV Ratio	1.04
P/FCF Ratio	0.95
P/OCF Ratio	0.87
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.57
EV / Sales	4.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	5.37

Financial Position

The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.41.

Current Ratio	0.97
Quick Ratio	0.44
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	1.90
Interest Coverage	-20.06

Financial Efficiency

Return on equity (ROE) is -31.28% and return on invested capital (ROIC) is -15.83%.

Return on Equity (ROE)	-31.28%
Return on Assets (ROA)	-9.00%
Return on Invested Capital (ROIC)	-15.83%
Return on Capital Employed (ROCE)	-17.91%
Weighted Average Cost of Capital (WACC)	3.04%
Revenue Per Employee	460.84M
Profits Per Employee	-274.23M
Employee Count	256
Asset Turnover	0.18
Inventory Turnover	1.41

Taxes

Income Tax	-1.74B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.42% in the last 52 weeks. The beta is 0.16, so KRX:007460's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	-57.42%
50-Day Moving Average	465.24
200-Day Moving Average	626.49
Relative Strength Index (RSI)	37.67
Average Volume (20 Days)	8,011,378

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:007460 had revenue of KRW 117.97 billion and -70.20 billion in losses. Loss per share was -236.00.

Revenue	117.97B
Gross Profit	31.17B
Operating Income	-95.57B
Pretax Income	-142.31B
Net Income	-70.20B
EBITDA	-84.69B
EBIT	-95.57B
Loss Per Share	-236.00

Balance Sheet

The company has 50.76 billion in cash and 187.86 billion in debt, with a net cash position of -137.10 billion or -444.35 per share.

Cash & Cash Equivalents	50.76B
Total Debt	187.86B
Net Cash	-137.10B
Net Cash Per Share	-444.35
Equity (Book Value)	458.61B
Book Value Per Share	513.89
Working Capital	-5.13B

Cash Flow

In the last 12 months, operating cash flow was 107.91 billion and capital expenditures -8.99 billion, giving a free cash flow of 98.92 billion.

Operating Cash Flow	107.91B
Capital Expenditures	-8.99B
Depreciation & Amortization	10.88B
Net Borrowing	101.47B
Free Cash Flow	98.92B
FCF Per Share	320.60

Margins

Gross margin is 26.42%, with operating and profit margins of -81.01% and -59.51%.

Gross Margin	26.42%
Operating Margin	-81.01%
Pretax Margin	-120.63%
Profit Margin	-59.51%
EBITDA Margin	-71.79%
EBIT Margin	-81.01%
FCF Margin	83.85%

Dividends & Yields

KRX:007460 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.24%
Shareholder Yield	-15.24%
Earnings Yield	-74.84%
FCF Yield	105.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 28, 2022. It was a reverse split with a ratio of 0.3333333333.

Last Split Date	Dec 28, 2022
Split Type	Reverse
Split Ratio	0.3333333333

Scores

Altman Z-Score	n/a
Piotroski F-Score	3